Display Settings:

Format

Send to:

Choose Destination
    J Rheumatol. 2001 Nov;28(11):2555-7.

    Arthritis following recombinant outer surface protein A vaccination for Lyme disease.

    Source

    Department of Pediatrics, duPont Hospital for Children, Wilmington, Delaware 19899, USA.

    Abstract

    As more individuals receive outer surface protein A (OspA) vaccination, adverse effects not detected during phase III clinical trials may become apparent. Although arthritis has been described following other human vaccines, we found no reports of human cases after Lyme disease vaccination. We describe 4 males (2 children, 2 adults) who developed arthritis following recombinant OspA vaccination. The potential arthritogenic effect of OspA suggested by in vitro and animal studies finds a clinical correlate in these 4 cases.

    PMID:
    11708435
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk